Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgd@hfea.gov.uk.

Condition name Status OMIM number Documents
Barth Syndrome approved 302060
Bartsocas-Papas syndrome (Popliteal Pterygium syndrome, lethal type) awaiting approval 263650
Bartsocas-Papas Syndrome (Popliteal Pterygium syndrome, lethal type) approved 263650
Bartter Syndrome Types 1, 2, 3, 4a & 4b (BARTS) approved 601678, 241200, 607364, 602522, 613090
Beare Stevenson syndrome approved 123790
Beckwith-Wiedemann Syndrome caused by a mutation in the CDKN1C gene or inheritance of a chromosome translocation, deletion or duplication affecting the chromosome 11 Beckwith Wiedemann syndrome region approved
Benign Chronic Pemphigus (BCPM) approved 169600
Beta Thalassaemia* approved 141900
Bethlem Myopathy approved 158810
Bilateral Frontoparietal Polymicrogyria (BFPP) approved 606854
Birt-Hogg-Dubé Syndrome approved 135150
Blepharophimosis, Ptosis & Epicanthus Inversus Syndrome Type 1 approved 110100
Blepharophimosis, Ptosis & Epicanthus Inversus Syndrome Type 2 approved 110100
Bloom Syndrome approved 210900
Branchio-oculo-facial Syndrome (BOFS) approved 113620
Branchio-Oto-Renal Syndrome 1 (BOR1) approved 113650
BRCA 1 (increased susceptibility to breast cancer) approved 113705
Breast Ovarian Cancer Familial Susceptibility (BRCA2) approved 612555, 600185
Brooke-Spiegler Syndrome (BSS) approved 605041
Brugada Syndrome 1 (Sudden Unexplained Nocturnal Death Syndrome (SUNDS)) approved 601144